Baker Bros. Advisors LP 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 4:11 pm Purchase |
2024-09-30 | 13G | AbCellera Biologics Inc. ABCL |
Baker Bros. Advisors LP | 27,525,640 9.300% |
4,615,887![]() (+20.15%) |
Filing |
2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | AbCellera Biologics Inc. ABCL |
Baker Bros. Advisors LP | 22,909,753 7.900% |
22,909,753![]() (New Position) |
Filing |